These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1425285

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy.
    Cooper ME, Allen TJ, O'Brien RC, Papazoglou D, Clarke BE, Jerums G, Doyle AE.
    Diabetes; 1990 Dec; 39(12):1575-9. PubMed ID: 2245881
    [Abstract] [Full Text] [Related]

  • 4. Controversies on the prevention of diabetic nephropathy.
    Chiarelli F, Verrotti A, Basciani F, di Ricco L, Sabatino G, Morgese G.
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():365-9. PubMed ID: 9642666
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Should normotensive diabetic patients with microalbuminuria be treated with angiotensin converting enzyme inhibitors?].
    Feldt-Rasmussen BF.
    Ugeskr Laeger; 2002 Apr 01; 164(14):1907-9. PubMed ID: 11957423
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Diabetic nephropathy: introduction.
    Breyer MD.
    Semin Nephrol; 2007 Mar 01; 27(2):129. PubMed ID: 17418681
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Angiotensin-converting enzyme inhibitors in the treatment of diabetic nephropathy].
    Sawicki PT, Mühlhäuser I, Berger M.
    Dtsch Med Wochenschr; 1994 Sep 23; 119(38):1298-9. PubMed ID: 7924925
    [No Abstract] [Full Text] [Related]

  • 16. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D.
    Semin Nephrol; 2007 Mar 23; 27(2):172-81. PubMed ID: 17418686
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Risk and prevention of diabetic nephropathy].
    Ravera M, Re M, Deferrari G.
    G Ital Nefrol; 2007 Mar 23; 24 Suppl 38():13-9. PubMed ID: 17922442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.